StonvexLoading…
StonvexStonvexStonvexCore line items from MDGL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $958.40M | $180.13M | $0.00 | $0.00 |
Operating Income | $-300.10M | $-497.88M | $-380.50M | $-293.57M |
Net Income | $-288.28M | $-465.89M | $-373.63M | $-295.35M |
EPS (Diluted) | $-12.85 | $-21.90 | $-19.99 | $-17.23 |
Total Assets | $1.26B | $1.04B | $640.55M | $362.57M |
Total Liabilities | $656.90M | $287.86M | $235.21M | $165.18M |
Cash & Equivalents | $198.69M | $100.02M | $99.92M | $331.55M |
Free Cash Flow OCF − CapEx | $-190.02M | $-457.03M | $-325.71M | $-225.07M |
Shares Outstanding | 22.84M | 22.00M | 19.88M | 18.10M |